Form 8-K - Current report:
SEC Accession No. 0001104659-06-028514
Filing Date
2006-04-28
Accepted
2006-04-28 06:04:23
Documents
9
Period of Report
2006-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-10673_18k.htm 8-K 66383
2 EX-3 a06-10673_1ex3d1.htm EX-3.1 7785
3 EX-10 a06-10673_1ex10d1.htm EX-10.1 72010
4 EX-99 a06-10673_1ex99d1.htm EX-99.1 9285
5 EX-99 a06-10673_1ex99d2.htm EX-99.2 17866
6 EX-99 a06-10673_1ex99d3.htm EX-99.3 14311
7 GRAPHIC g106731mqi001.jpg GRAPHIC 2727
8 GRAPHIC g106731mmi001.jpg GRAPHIC 2727
9 GRAPHIC g106731moi001.jpg GRAPHIC 2727
  Complete submission text file 0001104659-06-028514.txt   201411
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 06787002
SIC: 2835 In Vitro & In Vivo Diagnostic Substances